Skip to main content
Neuropsychiatric Disease and Treatment logoLink to Neuropsychiatric Disease and Treatment
. 2011 Nov 25;7:707. doi: 10.2147/NDT.S28295

Corrigendum

PMCID: PMC3255996  PMID: 22247611

Sailasuta N, Harris K, Tran T, Ross B. Minimally invasive biomarker confirms glial activation present in Alzheimer’s disease: a preliminary study. Neuropsychiatr Dis Treat. 2011;7:495–499.

Abstract: The third sentence should be ‘Calculation of the initial slope was similar in a single subject, examined twice, 4 months apart (test–retest 8%).’

Methods, ‘Patients’ section: The second line should be ‘A total of 24 MRI/MRS studies were performed on five subjects of whom one had AD, two had mild cognitive impairment (MCI) and two were healthy older adults with mean age of 78 ± 3 years, and two were females. The AD subject was examined twice.’

Methods, ‘Neuroimaging and Spectroscopy’ section: The following sentence should be added to the end, ‘Test–retest of 13C MRS in an AD was performed at 4 months with reproducibility of 8%.’

Table 1 has been revised, as shown below.

Table 1.

Compilations of subjects’ characteristics, proton, carbon MRS, and neuropsychological assessment results

Patient 1 control Patient 2 control Patient 3 MCI Patient 4 MCI Patient 5A* AD Patient 5B* AD
Subject characteristics
 Age 80 83 77 81 76
 Gender M M M M F
 MMSE 30 28 26 27 22
Proton MRS results
 NAA/Cr 1.45 1.37 1.47 1.37 1.62 1.39
 mi/Cr 0.56 0.72 0.77 0.74 0.85 0.83
 NAA/mi 2.6 1.92 1.92 1.85 1.34 1.67
Carbon MRS results
 Rate of bicarbonate production (% FE/minute) 0.023 0.03 0.042 0.033 0.056 0.06
Neuropsychological assessment (Z scores)
 Attention/concentration Working memory WNL WNL −2 WNL −1.6 −1.6
 Psychomotor/Information processing WNL WNL WNL WNL −1.5 −1.5
 Language functions WNL WNL −1.5 WNL −1.5 −1.5
 Verbal memory WNL WNL −1.3 −1.3 −3 −3
 Nonverbal memory WNL WNL −3 WNL −3 −3
 Visuospatial/construction WNL −1.4 −1.4 −2 −2 −2
 Executive functions WNL −1.4 −2.5 WNL −3 −3
 Motor functions WNL WNL −1.3 WNL WNL WNL
*

Notes: The AD subject was examined twice with a 4-month interval between studies.

Abbreviations: AD, Alzheimer’s disease; Cr, creatine; FE, fractional enrichment; mi, myoinositol; MCI, mild cognitive impairment; MMSE, mini-mental state examination; MRS, magnetic resonance spectroscopy; NAA, N-acetyl aspartate; WNL, within normal limits.


Articles from Neuropsychiatric Disease and Treatment are provided here courtesy of Dove Press

RESOURCES